North America Prostate Cancer Nuclear Medicine Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (PET and SPECT), PET Product (F-18, C-11, and Ga68-PSMA), and End User (Hospitals, Clinics, and Others)

No. of Pages: 114    |    Report Code: BMIRE00025677    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Prostate Cancer Nuclear Medicine Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Prostate Cancer Nuclear Medicine Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Prostate Cancer Nuclear Medicine Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. North America Prostate Cancer Nuclear Medicine Market Regional Analysis

6.1 North America Prostate Cancer Nuclear Medicine Market Overview
6.2 North America Prostate Cancer Nuclear Medicine Market Revenue 2020-2028 (US$ Million)
6.3 North America Prostate Cancer Nuclear Medicine Market Forecast Analysis

7. North America Prostate Cancer Nuclear Medicine Market Analysis – by Type

7.1 PET
  • 7.1.1 Overview
  • 7.1.2 PET: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2031 (US$ Million)
7.2 SPECT
  • 7.2.1 Overview
  • 7.2.2 SPECT: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Prostate Cancer Nuclear Medicine Market Analysis – by PET Product

8.1 F-18
  • 8.1.1 Overview
  • 8.1.2 F-18: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
8.2 C-11
  • 8.2.1 Overview
  • 8.2.2 C-11: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Ga68-PSMA
  • 8.3.1 Overview
  • 8.3.2 Ga68-PSMA: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Prostate Cancer Nuclear Medicine Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Ga68-PSMA: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Ga68-PSMA: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Prostate Cancer Nuclear Medicine Market – North America Analysis

10.1 North America
  • 10.1.1 North America Prostate Cancer Nuclear Medicine Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.1.1.1.3 US: North America Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.1.1.2.3 Canada: North America Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.1.1.3.3 Mexico : North America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Prostate Cancer Nuclear Medicine Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Blue Earth Diagnostics Limited
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 ImaginAb
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Curium
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Jubilant Radiopharma
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NCM-USA LLC
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 ABX advanced biochemical compounds GmbH
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Telix Pharmaceuticals Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Novartis AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Theragnostics
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Lantheus Medical Imaging, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Blue Earth Diagnostics Limited
  2. ImaginAb
  3. Curium
  4. Jubilant Radiopharma
  5. NCM-USA LLC
  6. ABX advanced biochemical compounds GmbH
  7. Telix Pharmaceuticals Ltd
  8. Novartis AG
  9. Theragnostics
  10. Lantheus Medical Imaging, Inc.
north-america-prostate-cancer-nuclear-medicine-market